Estrogen in the medial preoptic area of male rats facilitates copulatory behavior.
Mating was studied in sexually experienced, gonadally intact male rats assigned to two surgical groups matched on the basis of mean mounting frequency during behavioral screening trials conducted prior to the study. Estradiol (E(2)) was delivered bilaterally into the medial preoptic area (MPO) of experimental males by means of hormone-coated implants, and fadrozole was given sc (0.25 mg/kg/day) via osmotic minipumps to block E(2) formation from testicular testosterone throughout the brain. Control males received blank bilateral implants in the MPO and sc fadrozole. After the completion of behavioral testing, immunocytochemical comparisons of the brains from experimental and control rats were made using the H222 antiestrogen receptor (ER) antibody, whose labeling is inhibited by the presence of E(2). The histology demonstrated that E(2) was confined exclusively to the MPO of experimental males but was absent throughout the brains of controls. In controls, mounting decreased significantly by the 7th day after surgery compared with presurgical levels and did not recover. In contrast, on all postsurgical days, the mounting frequency of the experimental group was significantly higher than that of controls. Although experimental males also showed an initial, significant postsurgical decline in mounting frequency, it recovered completely by the 28th postoperative day. Ejaculations declined significantly after surgery in both groups but, unlike in controls whose performance remained low, ejaculations in experimental males partially recovered and were significantly higher than in controls during the postoperative period. Results showed that ER-containing neurons in the MPO influence male rat copulatory behavior.
Clancy
A N
AN
Department of Biology, Georgia State University, Kell Hall, 24 Peachtree Center Avenue, Atlanta, Georgia, 30302-4010, USA.
Zumpe
D
D
Michael
R P
RP
D000818:Animals; D004343:Drug Implants; D004542:Ejaculation / Q000187:drug effects / Q000502:physiology; D004958:Estradiol / Q000494:pharmacology; D004965:Estrogen Antagonists / Q000494:pharmacology; D004967:Estrogens / Q000502:physiology*; D017316:Fadrozole / Q000494:pharmacology; D005260:Female; D007279:Injections, Subcutaneous; D008297:Male; D011301:Preoptic Area / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012726:Sexual Behavior, Animal / Q000187:drug effects / Q000502:physiology*
D004343:Drug Implants; D004965:Estrogen Antagonists; D004967:Estrogens; D004958:Estradiol; D017316:Fadrozole